摘要
医学人工智能社会实验旨在更全面了解医学人工智能技术和产品对社会带来的综合影响,具有应用场景广泛、研究类型和方法复杂、评价指标多维、学科交叉、主体多元等特点,为确保医学人工智能社会实验伦理审查质量,迫切需要政府主管部门、研究发起方、医疗卫生机构、高等院校、科研机构、企业及研究团队等相关方各负其责,建立医学人工智能社会实验的技术产品准入机制,提高伦理审查委员会伦理审查能力,并构建全周期监管体系。
The medical artificial intelligence(AI)social experiment aims to more comprehensively understand the comprehensive impact of medical AI technologies and products on society,with the characteristics of wide application scenarios,complex research types and methods,multi-dimensional evaluation indicators,crossdisciplinary,and diverse subjects.To ensure the quality of ethical review in medical AI social experiment,it is urgent for relevant parties such as government authorities,research initiators,medical and health institutions,universities,scientific research institutions,enterprises,and research teams to shoulder their respective responsibilities,establish a technology product access mechanism for medical AI social experiments,improve the ethical review ability of the ethical review committee,and construct a whole cycle regulatory system.
作者
祝丹娜
吉萍
ZHU Danna;JI Ping(Institute of Clinical Research,Shenzhen PKU-HKUST Medical Center,Shenzhen 518036,China)
出处
《中国医学伦理学》
北大核心
2024年第2期210-213,共4页
Chinese Medical Ethics
基金
深圳市科技计划项目软科学研究“超大型城市人工智能干预青少年抑郁症社会实验”(RKX20220705152815035)
深圳市卫健委项目“深圳市医学人工智能社会治理实验伦理管理研究”(2021B0038)。
关键词
医学人工智能
社会实验
伦理审查
medical artificial intelligence
social experiment
ethical review
